Synergetic effect of matrine on the catalytic scFv antibody HS72 in vitro and in mice with Alzheimer disease pathology
Authors:
- 31 October 2023
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 242, 109775
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31970883)
This publication has 32 references indexed in Scilit:
- Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibodyAlzheimer's Research & Therapy, 2016
- Evolving synergistic combinations of targeted immunotherapies to combat cancerNature Reviews Cancer, 2015
- Functional Characteristics and Molecular Mechanism of a New scFv Antibody Against Aβ42 Oligomers and Immature ProtofibrilsMolecular Neurobiology, 2014
- Aβ(39–42) Modulates Aβ Oligomerization but Not Fibril FormationBiochemistry, 2011
- Biophysical Characterization of Aβ42 C-Terminal Fragments: Inhibitors of Aβ42 NeurotoxicityBiochemistry, 2010
- Recombinant GST-I-Aβ28-induced efficient serum antibody against Aβ42Journal of Neuroscience Methods, 2010
- Allosteric Regulation of ProteasesChemBioChem, 2008
- C-terminal peptides coassemble into Aβ42 oligomers and protect neurons against Aβ42-induced neurotoxicityProceedings of the National Academy of Sciences, 2008
- Role of Na+and K+in Enzyme FunctionPhysiological Reviews, 2006
- Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assembliesJournal of Neuroscience Research, 2002